Jade Biosciences, Inc.

NASDAQ:JBIO

Biotechnology

Healthcare
$15.49 -1.25%

-$0.21 today

Market cap
$1.07B
Beta
1.45
P/E (TTM)
-7.4
EPS (TTM)
-$2.24
52W Low $6.67High $28.00

Volume 0.79M

Average 0.83M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$113.54M

FY 2025 · Annual

Net Income

-$127.41M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue15K68K96K282K0
Gross Profit(15K)(68K)(96K)(282K)0
Gross Margin—————
Research & Development14.99M38.62M64.22M53.19M93.12M
Selling, General & Admin8.02M14.55M17.09M21.13M20.42M
Operating Expenses23.01M53.17M81.31M74.31M113.54M
Depreciation & Amortization15K68K96K282K26K
EBITDA(22.95M)(51.42M)(75.37M)(69.29M)(127.33M)
EBITDA Margin—————
Operating Income(23.02M)(53.24M)(81.41M)(74.6M)(113.54M)
Operating Margin—————
Interest Income65K1.83M5.95M5.04M7.78M
Interest Expense00000
Other Income / Expenses62K1.75M5.94M5.02M(13.81M)
Income Before Tax(22.96M)(51.49M)(75.47M)(69.57M)(127.35M)
Pre-Tax Margin—————
Income Tax Expense3K25K56K55K58K
Net Income(22.96M)(51.51M)(75.52M)(69.63M)(127.41M)
Net Margin—————
EPS (Basic)(32.96)(73.67)(100.38)(85.26)(4.06)
EPS (Diluted)(32.96)(73.67)(100.38)(85.26)(4.06)
Weighted Avg Shares697.44K699.2K752.33K816.63K31.36M
Weighted Avg Shares (Diluted)697.44K699.2K752.33K816.63K31.36M

JBIO Earnings Waterfall · TTM

NASDAQ:JBIO · Revenue to Net Income

Key Ratios

EPS$-3.12
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.8
P/S Ratio0.0

Analysis

$0 of revenue converted into -$129.6M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-3.12, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
SC 13GSC 13G filingOct 28, 2026
SC 13GSC 13G filingOct 27, 2026
424B5424B5 filingJun 3, 2026

How much revenue does JBIO generate?

Jade Biosciences, Inc. (JBIO) reported $0.00 of revenue in fiscal 2025.

Is JBIO profitable?

Jade Biosciences, Inc. (JBIO) reported -$127.41M of net income.